{"id":561,"date":"2024-08-14T23:40:30","date_gmt":"2024-08-14T23:40:30","guid":{"rendered":"https:\/\/rafconsulting.net\/eng\/blog\/?p=561"},"modified":"2024-08-15T00:05:02","modified_gmt":"2024-08-15T00:05:02","slug":"do-you-know-how-to-report-adverse-drug-reactions-adrs-notifications","status":"publish","type":"post","link":"https:\/\/rafconsulting.net\/eng\/blog\/do-you-know-how-to-report-adverse-drug-reactions-adrs-notifications\/","title":{"rendered":"Do you know how to report adverse drug reactions (ADRs) notifications?"},"content":{"rendered":"\n<p>Cofepris, in an attempt to encourage the reporting of adverse reactions by consumers and healthcare professionals, launched a new platform for notifications. This new platform is called VigiRam, which promises to be more user-friendly for the notifier and avoids discouraging the reporting process.<br><\/p>\n\n\n\n<p>VigiRam is an application that can be installed on a mobile phone; it contains the complete electronic standardised format for reporting suspected adverse drug reactions. Notifications sent through this platform are encrypted and transmitted directly to the National Pharmacovigilance Center (CNFV).<\/p>\n\n\n\n<p><br>VigiRam allows data\/information capture without an internet connection, and it does not require users to register or create an account to use the tool; however, an internet connection is required to submit the captured information. It is important to mention that it allows sending notifications with the minimum required information. Each time a notification is sent, the application will confirm that the information was sent successfully and provides receipt acknowledgment.<\/p>\n\n\n\n<p><br>This new method for reporting adverse reactions appears to be a more user-friendly tool compared to an email address or a phone call, which can take several minutes, and many people tend to avoid answering calls of uncertain duration.<\/p>\n\n\n\n<p><br>The challenge now is to promote this tool among healthcare professionals and health institutions to encourage consumers to report adverse drug reactions in Mexico, which will help optimise drug safety.<\/p>\n\n\n\n<p>You can download the information here:<\/p>\n\n\n\n<figure class=\"wp-block-image\"><img decoding=\"async\" src=\"https:\/\/lh7-rt.googleusercontent.com\/docsz\/AD_4nXeBnrtcHMnmnZX3HBFOA2xGaRWav5eYmmHWiob3x6c8EmVEHIMRs5JEayjbt0JIcnf35t84p7RCfJZb7kPxCrOXvXS061GGpcGbN29lGgypSoEU7EyK-NTtfTWaNG5ci8Y7tAk4WeWYysAuXzVQdDKOEJvwaMGlO8JFOmwgeGKLd9EuWddqHyQ?key=Ohzz9KnwdfEwzRx4Jnz7-Q\" alt=\"\"\/><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>Cofepris, in an attempt to encourage the reporting of adverse reactions by consumers and healthcare professionals, launched a new platform for notifications. This new platform is called VigiRam, which promises to be more user-friendly for the notifier and avoids discouraging the reporting process. VigiRam is an application that can be installed on a mobile phone; [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":565,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[95],"tags":[111,109,113,112,11,107,108,110],"class_list":["post-561","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharmacovigilance","tag-adrs","tag-adverse-reaction","tag-cemar","tag-cnfv","tag-cofepris","tag-medication","tag-notification","tag-vigiram"],"_links":{"self":[{"href":"https:\/\/rafconsulting.net\/eng\/blog\/wp-json\/wp\/v2\/posts\/561","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rafconsulting.net\/eng\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/rafconsulting.net\/eng\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/rafconsulting.net\/eng\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/rafconsulting.net\/eng\/blog\/wp-json\/wp\/v2\/comments?post=561"}],"version-history":[{"count":1,"href":"https:\/\/rafconsulting.net\/eng\/blog\/wp-json\/wp\/v2\/posts\/561\/revisions"}],"predecessor-version":[{"id":563,"href":"https:\/\/rafconsulting.net\/eng\/blog\/wp-json\/wp\/v2\/posts\/561\/revisions\/563"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/rafconsulting.net\/eng\/blog\/wp-json\/wp\/v2\/media\/565"}],"wp:attachment":[{"href":"https:\/\/rafconsulting.net\/eng\/blog\/wp-json\/wp\/v2\/media?parent=561"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/rafconsulting.net\/eng\/blog\/wp-json\/wp\/v2\/categories?post=561"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rafconsulting.net\/eng\/blog\/wp-json\/wp\/v2\/tags?post=561"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}